Home > Press > API Nanotronics Reports Record First Quarter Revenues of $7.9 Million
Abstract:
Company Implements Cost-Saving Consolidation and Continues to Invest in Next Generation Nanotechnology Products
API Nanotronics Corp. (OTCBB: APIA) ("API") (the "Company"), a leading supplier of electronic components, nano-optics and nanotechnology research and development to the defense and communications sectors, today announced first quarter operating results for the period ended August 31, 2008.
Financial Highlights for the First Quarter 2009
-- Net revenue for the first quarter of fiscal 2009 was $7.9 million, an
11% increase over fiscal 2008 first quarter revenue of $7.1 million;
-- Gross profit increased to $2.1 million in the first quarter of fiscal
2009 compared to $2.0 million in the first quarter of fiscal 2008 as the
Company began to restructure its domestic operations and transfer select
manufacturing to China;
-- GAAP net loss for the quarter was $0.89 million or $0.03 per share,
compared to a loss of $0.71 million or $0.03 per share in the first quarter
of 2008. The GAAP loss includes a charge of $0.22 million related to
restructuring and the consolidation of facilities. The loss also includes
non-cash charges related to stock-based compensation and depreciation
totaling $0.53 million. Excluding restructuring expenses, non-cash charges
and nanotechnology R&D expenses of $0.94 million, non-GAAP net income was
$0.80 million, compared to $0.12 million in the previous year; and
-- Balance sheet remains strong with over $4.2 million in cash and
marketable securities and $0.10 million of long term debt.
Reconciliations of non-GAAP measures to GAAP net profit (loss) are included at the end of this release.
Operating Highlights
-- During the first quarter of fiscal 2009, API continued to implement a
series of initiatives to consolidate its physical plants and streamline
manufacturing through greater outsourcing, while improving profitability
and achieving significant progress in its nanotechnology endeavors;
-- Three locations have been shut down and the business activities moved
to the Company's Ronkonkoma NY, Somerset NJ and Ottawa Canada sites;
-- The Company expanded its presence in China, completing the process of
qualifying facilities for its magnetics products and is now able to deliver
a range of products designed by its engineering team and manufactured in
China with impressive quality and pricing;
-- In July, API announced it received two 2008 NanoBriefs® Nano 50™
awards. Dr. Martin Moskovits, API's Chief Technology Officer, was honored
as a Nano 50 Innovator and API's SubWave™ UV Polarizers were honored
with a Nano 50 product award;
-- The Company secured a large $4.7 million order from Rockwell Collins,
expanding its long standing business relationship with the leading
military aircraft electronics supplier; and
-- The Aries series of 1553 terminals, featuring IP developed in
partnership with Sital Technology, an Israeli company specializing in 1553
software solutions, has been qualified by a major defense prime as a pin-
for-pin replacement with superior characteristics for a competitor's
product.
Stephen B. Pudles, Chief Executive Officer of API Nanotronics Inc., said, "We are working to maximize profitability and the value of the business. Revenues continue to grow and the nanotechnology platform is proving successful when applied to a variety of sophisticated optical component solutions. We believe the steps we are taking will deliver tangible positive results in the immediate future."
####
About API Nanotronics Corp.
API Nanotronics Corp., through its wholly owned subsidiaries API Electronics Inc., National Hybrid Inc., Filtran Group, TM Systems, Keytronics and API Nanofabrication Corporation, is engaged in the manufacture of electronic components and systems for the defense and communications industries. API is also developing a leadership position in the R&D and manufacture of nanotechnology and MEMS products. With a growing list of blue chip customers, including Honeywell/Allied Signal, General Dynamics, Lockheed Martin, and numerous other top technology-based firms around the world, API regularly ships products to clients in more than 34 countries. API owns state-of-the-art manufacturing and technology centers in New York, New Jersey and Ontario, Canada and has manufacturing capabilities in China and a distribution center in Britain. API Nanotronics trades on the OTC Bulletin Board under the symbol APIA.
Safe Harbor for Forward-Looking Statements:
Except for statements of historical fact, the information presented herein constitutes forward-looking statements. All forward-looking statements are subject to certain risks, uncertainties and assumptions which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks and uncertainties, which are more fully described in the Company's Annual and Quarterly Reports filed with the Securities and Exchange Commission, include but are not limited to, general economic and business conditions, the ability to acquire and develop specific projects, the ability to fund operations and changes in consumer and business consumption habits, our ability to protect our intellectual property, our ability to integrate and consolidate our operations, our ability to expand our operations in both new and existing markets, the effect of growth on our infrastructure and the effect of competition in the electronic components, nano-optics and nanotechnology industries. Should one or more of these risks or uncertainties materialize, or should the assumptions prove incorrect, actual results may vary in material aspects from those currently anticipated. All information in this release is as of the date hereof. We undertake no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.
In this press release, API has provided a non-GAAP financial measure for (i) net profit (loss) to reflect its financial results without charges related to restructuring, depreciation and stock-based compensation expense. Management believes the non-GAAP presentations make it easier for investors to compare current and historical period operating results. These are not recognized measures under US GAAP, do not have a standardized meaning, and are unlikely to be comparable to similar measures used by other companies. Accordingly, investors are cautioned that these non-GAAP measures should not be construed as an alternative to net earnings or loss determined in accordance with GAAP as an indicator of the financial performance of the Company or as a measure of the Company's liquidity and cash flows.
The following table reconcilesfirst quarter GAAP net income (loss) to non-GAAP net income (loss).
Net Income (Loss) (In millions) Q108 Q107 GAAP Net income (loss) $ (0.89) $ (0.71) Restructuring Charge $ 0.22 -- Research & Development $ 0.94 $ 0.28 Depreciation $ 0.30 $ 0.20 Stock-based compensation expense $ 0.23 $ 0.35 Non-GAAP Net income $ 0.80 $ 0.12
For more information, please click here
Contacts:
Steve Bulwa
Director of Corporate Communications
API Nanotronics Corp.
1-877-API-O-API (274-0274)
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||